Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice
Semaglutide / Cyanocobalamin Injection GLP-1 + Vitamin B12 A compounded subcutaneous injection combining Semaglutide (GLP-1 receptor agonist) with Cyanocobalamin (Vitamin B12) to support weight management, glycemic control, and overall metabolic health with B12 added to help offset the nutritional depletion associated with caloric restriction and reduced appetite
Store the lyophilised solid in a desiccated environment at -20C out of direct light
Lipo and B12 shots should always be administered by a licensed medical professional in a clinical setting
Existing literature points strongly to 5-Amino-1MQ
AHK-Cu, by contrast, is entirely synthetic